Table 1.
Parameters | MS patients | Healthy controls | Statistical comparison |
---|---|---|---|
Number of subjects | 22 | 18 | |
Median age | 34 | 34.5 | |
Age range | 22–55 | 26–55 | Independent two sample t‐test; p = 0.7339 |
Gender ratio (male:female) | 1:1.2 | 1:1 | Chi square test, p = 0.7746 |
AHSCT, Autologous haematopoietic stem cell transplantation; ATG, Anti‐thymocyte globulin; BEAM, Carmustine, Etoposide, Cytarabine, Melphalan; cTfh, Circulating T follicular helper; DMT, Disease modifying therapies; HCs, Healthy controls; M, Months; MAIT, Mucosal‐associated invariant T; MS, Multiple Sclerosis; NK, Natural Killer; PD1, Programmed cell death protein 1; T‐conv, T‐conventional; Th17, T helper 17; Tregs, T regulatory cells; yr, Year.